- Evolving Treatment Paradigms in HER2+ Breast Cancers
- Optimizing CDK4/6i-Based Therapies in HR+/HER2- mBC: From Adjuvant to Frontline Settings
- Clinical Scenarios: CDK4/6i in HR+ mBC
- Post-Frontline CDK4/6: How do you sequence in Advanced/Metastatic Breast Cancer?
- Antibody-Drug Conjugates (ADC) for Breast Cancer
- ASCO 2025 updates
OncLive® State of the Science Summit™ Breast Cancer
The Westin Tysons Corner
7801 Leesburg Pike
Falls Church, VA 22043
Tuesday, June 17, 2025
6:00 PM - 8:45 PM ET
Complimentary Parking
In-Person Only
Event Chair
Jennifer Matro, MD
Inova Health
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512